BeneSol Inc. – Trademark Portfolio
Entity Type: 03
BeneSol Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 6 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SOLIUS. The owner is based in Bainbridge Island, WA.
100 Ravine Lane NE, Suite 310
Bainbridge Island, WA 98110
Showing of trademarks Trademarks
Trademark Classifications
BeneSol Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does BeneSol Inc. have?
BeneSol Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 2 registered, 8 abandoned, 1 cancelled.
What trademark classes does BeneSol Inc. file in?
BeneSol Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 37 (Building & Construction), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are BeneSol Inc.'s most well-known trademarks?
BeneSol Inc.'s registered trademark portfolio includes well-known marks such as SOLIUS. These are among 2 currently registered trademarks in the portfolio.
What is BeneSol Inc.'s trademark registration success rate?
BeneSol Inc. has a 18% trademark registration rate, with 2 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.